Humanigen Inc (fka HGENQ)

[cowtown jay]

I think the potential for lenz continues to be under-estimated. I hope that the company is accumulating data in regards to viral load. Right now, we see that the company has gained enough confidence to claim that lenz is effective as a preventive to the development of cytokine storm.

But, we should be focused on substantiating what else lenz does, in terms of reducing viral load. With our reported recovery time, common sense indicates that viral load is reduced in these patients faster than with any other treatment. Our competitor describes their product as follows.

"The leronlimab antibody appears to be a powerful antiviral agent..." Since that drug targets a receptor cell, whereas we target the upstream ligand, we should have better viral load results. And I think it is important to verify what lenz does in reducing viral load.

I would be interested in seeing what lenz does when infused into a healthy population of test subjects. What percentage of those people subsequently develop Covid-19 infection? That's what PFE/BNTX did.